National Bank of Canada’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

National Bank of Canada’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,228	Closed	-$2.79K	–	2904
2022 Q4	$2.79K	Sell	1,228 -420	-25%	-$1.29K	﹤0.01%	2437
2022 Q3	$5K	Sell	1,648 -200	-11%	-$651	﹤0.01%	2356
2022 Q2	$10K	Sell	1,848 -70,200	-97%	-$218K	﹤0.01%	2280
2022 Q1	$168K	Sell	72,048 -164,667	-70%	-$561K	﹤0.01%	1551
2021 Q4	$1.43M	Buy	+236,715	New	+$2.28M	﹤0.01%	925

Other funds holding GRCL

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

National Bank of Canada's GRCL Position: Q1 2023 in Review

National Bank of Canada sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2023, closing a stake of 1,228 shares — an estimated $2.79K sold.

National Bank of Canada first reported a position in GRCL in Q4 2021 and held it in 5 quarters. The position peaked at $1.43M in Q4 2021. 33 funds tracked by Wall St. Rank hold GRCL as of Q1 2023.

National Bank of Canada reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2023 after selling out during the quarter.
National Bank of Canada sold 1,228 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2023, an estimated $2.79K.
National Bank of Canada first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2021 and held it in 5 quarters.
National Bank of Canada's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.43M in Q4 2021.
33 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.